8月22日周五，医渡科技（02158.HK）股价在盘中大涨5.02%，引发市场关注。这波涨势背后有两大利好消息推动。
首先，医渡科技与广东医科大学附属医院联合研发的"美易智能体"在近日举行的学术年会上亮相。这是医渡科技大模型技术首次应用于医美领域，展现了公司在人工智能医疗方面的技术实力和创新能力。该智能体能够实现数据价值向临床应用的转化，有望为医美行业带来革新。
其次，医渡科技在海南省推行的数字疗法项目取得显著进展。在陵水县的试点中，99.09%的在管患者已纳入系统化照护，血糖指标达标率明显提升。公司计划将此成功模式推广至三亚、万宁等多个城市，并拓展到高血压等更多慢性病种。医渡科技预计2025年内将覆盖管理超过10万名区域患者，显示出公司在数字健康领域的巨大发展潜力。这些积极进展无疑增强了投资者对公司未来成长的信心，推动了股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.